Cargando…
Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer
With docetaxel as effective chemotherapy for hormone refractory prostate cancer (HRPC), the number of new treatment combinations for HRPC is expanding demanding a fast-track screening system. This review elaborates on the use of xenograft models to select the most promising combination therapies for...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634688/ https://www.ncbi.nlm.nih.gov/pubmed/19088719 http://dx.doi.org/10.1038/sj.bjc.6604822 |
_version_ | 1782164144198254592 |
---|---|
author | van Weerden, W M Bangma, C de Wit, R |
author_facet | van Weerden, W M Bangma, C de Wit, R |
author_sort | van Weerden, W M |
collection | PubMed |
description | With docetaxel as effective chemotherapy for hormone refractory prostate cancer (HRPC), the number of new treatment combinations for HRPC is expanding demanding a fast-track screening system. This review elaborates on the use of xenograft models to select the most promising combination therapies for entering into phase II clinical trials. |
format | Text |
id | pubmed-2634688 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-26346882010-01-13 Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer van Weerden, W M Bangma, C de Wit, R Br J Cancer Review With docetaxel as effective chemotherapy for hormone refractory prostate cancer (HRPC), the number of new treatment combinations for HRPC is expanding demanding a fast-track screening system. This review elaborates on the use of xenograft models to select the most promising combination therapies for entering into phase II clinical trials. Nature Publishing Group 2009-01-13 2008-12-16 /pmc/articles/PMC2634688/ /pubmed/19088719 http://dx.doi.org/10.1038/sj.bjc.6604822 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review van Weerden, W M Bangma, C de Wit, R Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer |
title | Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer |
title_full | Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer |
title_fullStr | Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer |
title_full_unstemmed | Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer |
title_short | Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer |
title_sort | human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634688/ https://www.ncbi.nlm.nih.gov/pubmed/19088719 http://dx.doi.org/10.1038/sj.bjc.6604822 |
work_keys_str_mv | AT vanweerdenwm humanxenograftmodelsasusefultoolstoassessthepotentialofnoveltherapeuticsinprostatecancer AT bangmac humanxenograftmodelsasusefultoolstoassessthepotentialofnoveltherapeuticsinprostatecancer AT dewitr humanxenograftmodelsasusefultoolstoassessthepotentialofnoveltherapeuticsinprostatecancer |